Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2020-02-05 | 2020-03-11 | 105359 |
| APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2023-05-26 | 2023-06-02 | 193209 |
| APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2024-05-24 | 2024-07-19 | 228777 |
| APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2025-06-12 | 2025-07-25 | 260147 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Resolved | 2017-09-04 | 2017-11-27 | 20909 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Resolved | 2019-05-15 | 2019-12-09 | 84154 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 224990 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Resolved | 2024-06-13 | 2024-07-19 | 230480 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-10 | 2017-05-13 | 9946 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-17 | 2017-10-24 | 15995 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-26 | 2017-11-13 | 17331 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-28 | 2018-01-22 | 31039 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-15 | 2019-02-21 | 72363 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-24 | 2019-06-21 | 82337 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-05-15 | 2019-06-24 | 84159 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-06-05 | 2019-06-21 | 85619 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-02 | 2021-02-23 | 123581 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-17 | 2021-02-23 | 124359 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-07 | 2021-02-23 | 125824 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-08-19 | 2022-10-14 | 167421 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |